Human neural stem cell extracellular vesicles improve recovery in a porcine model of ischemic stroke

Stroke

Volumn 49, Issue 5, 2018, Pages 1248-1256

  Webb, Robin L ^a,b   Kaiser, Erin E ^b   Jurgielewicz, Brian J ^b   Spellicy, Samantha ^b   Scoville, Shelley L ^a   Thompson, Tyler A ^a   Swetenburg, Raymond L ^a   Hess, David C ^c   West, Franklin D ^b   Stice, Steven L ^a,b  

^a Aruna Biomedical   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Brain ischemia; Extracellular vesicles; Magnetic resonance imaging; Stroke; White matter

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BRAIN DAMAGE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; CONVALESCENCE; CORPUS CALLOSUM; DIFFUSION WEIGHTED IMAGING; EXOSOME; EXPLORATORY BEHAVIOR; FRACTIONAL ANISOTROPY; GAIT; HUMAN; HUMAN CELL; INTERFERENCE MICROSCOPY; LESION VOLUME; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR ACTIVITY; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NONHUMAN; PORCINE MODEL; PRIORITY JOURNAL; WHITE MATTER; ANIMAL; ANIMAL BEHAVIOR; ANISOTROPY; BRAIN; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC IMAGING; DISEASE MODEL; NEURAL STEM CELL; PATHOPHYSIOLOGY; PIG; TRANSPLANTATION;

ANIMALS; ANISOTROPY; BEHAVIOR, ANIMAL; BRAIN; BRAIN EDEMA; BRAIN ISCHEMIA; CORPUS CALLOSUM; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; EXTRACELLULAR VESICLES; GAIT; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; NEURAL STEM CELLS; RECOVERY OF FUNCTION; STROKE; SWINE; WHITE MATTER;

EID: 85048540982     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.117.020353     Document Type: Article

References (49)

1. Cheng NT, Kim AS. Intravenous thrombolysis for acute ischemic stroke within 3 hours versus between 3 and 4.5 hours of symptom onset. Neurohospitalist. 2015;5:101-109. doi: 10.1177/1941874415583116.
2. Boyle K, Joundi RA, Aviv RI. An historical and contemporary review of endovascular therapy for acute ischemic stroke. Neurovasc Imaging. 2017;3:1.
3. Stem Cell Therapies as an Emerging Paradigm in Stroke Participants. Stem cell therapies as an emerging paradigm in stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke. 2009;40:510-515. doi: 10.1161/STROKEAHA.108.526863.
4. Savitz SI, Chopp M, Deans R, Carmichael T, Phinney D, Wechsler L; STEPS Participants. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke. 2011;42:825-829. doi: 10.1161/STROKEAHA.110.601914.
5. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al; STAIR Group. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40:2244-2250. doi: 10.1161/STROKEAHA.108.541128.
6. Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M; STAIR VI Consortium. Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke. 2009;40:2594-2600. doi: 10.1161/STROKEAHA.109.552554.
7. Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G, et al. Applying extracellular vesicles based therapeutics in clinical trials-an ISEV position paper. J Extracell Vesicles. 2015;4:30087.
8. Basso M, Bonetto V. Extracellular vesicles and a novel form of communication in the brain. Front Neurosci. 2016;10:127. doi: 10.3389/fnins.2016.00127.
9. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373-383. doi: 10.1083/jcb.201211138.
10. György B, Hung ME, Breakefield XO, Leonard JN. Therapeutic applications of extracellular vesicles: clinical promise and open questions. Annu Rev Pharmacol Toxicol. 2015;55:439-464. doi: 10.1146/annurev-pharmtox-010814-124630.
11. Doeppner TR, Herz J, Görgens A, Schlechter J, Ludwig AK, Radtke S, et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015;4:1131-1143. doi: 10.5966/sctm.2015-0078.
12. Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab. 2013;33:1711-1715. doi: 10.1038/jcbfm.2013.152.
13. Zhang Y, Chopp M, Zhang ZG, Katakowski M, Xin H, Qu C, et al. Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury. Neurochem Int. 2017;111:69-81. doi: 10.1016/j.neuint.2016.08.003.
14. Wiklander OP, Nordin JZ, O'Loughlin A, Gustafsson Y, Corso G, Mäger I, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4:26316.
15. Webb RL, Kaiser EE, Scoville SL, Thompson TA, Fatima S, Pandya C, et al. Human neural stem cell extracellular vesicles improve tissue and functional recovery in the murine thromboembolic stroke model [published online ahead of print December 28, 2017]. Transl Stroke Res. doi: 10.1007/s12975-017-0599-2. https://link.springer.com/article/10. 1007/s12975-017-0599-2.
16. Platt SR, Holmes SP, Howerth EW, Duberstein KJJ, Dove CR, Kinder HA, et al. Development and characterization of a Yucatan miniature biomedical pig permanent middle cerebral artery occlusion stroke model. Exp Transl Stroke Med. 2014;6:5. doi: 10.1186/2040-7378-6-5.
17. Duberstein KJ, Platt SR, Holmes SP, Dove CR, Howerth EW, Kent M, et al. Gait analysis in a pre- and post-ischemic stroke biomedical pig model. Physiol Behav. 2014;125:8-16. doi: 10.1016/j.physbeh.2013.11.004.
18. Lind NM, Moustgaard A, Jelsing J, Vajta G, Cumming P, Hansen AK. The use of pigs in neuroscience: modeling brain disorders. Neurosci Biobehav Rev. 2007;31:728-751. doi: 10.1016/j.neubiorev.2007.02.003.
19. Nakamura M, Imai H, Konno K, Kubota C, Seki K, Puentes S, et al. Experimental investigation of encephalomyosynangiosis using gyrencephalic brain of the miniature pig: histopathological evaluation of dynamic reconstruction of vessels for functional anastomosis. Laboratory investigation. J Neurosurg Pediatr. 2009;3:488-495. doi: 10.3171/2008.6.PEDS0834.
20. Kuluz JW, Prado R, He D, Zhao W, Dietrich WD, Watson B. New pediatric model of ischemic stroke in infant piglets by photothrombosis: acute changes in cerebral blood flow, microvasculature, and early histopathology. Stroke. 2007;38:1932-1937. doi: 10.1161/STROKEAHA.106.475244.
21. Tanaka Y, Imai H, Konno K, Miyagishima T, Kubota C, Puentes S, et al. Experimental model of lacunar infarction in the gyrencephalic brain of the miniature pig: neurological assessment and histological, immunohistochemical, and physiological evaluation of dynamic corticospinal tract deformation. Stroke. 2008;39:205-212. doi: 10.1161/STROKEAHA.107.489906.
22. Baltan S, Besancon EF, Mbow B, Ye Z, Hamner MA, Ransom BR. White matter vulnerability to ischemic injury increases with age because of enhanced excitotoxicity. J Neurosci. 2008;28:1479-1489. doi: 10.1523/JNEUROSCI.5137-07.2008.
23. Baker EW, Platt SR, Lau VW, Grace HE, Holmes SP, Wang L, et al. Induced pluripotent stem cell-derived neural stem cell therapy enhances recovery in an ischemic stroke pig model. Sci Rep. 2017;7:10075. doi: 10.1038/s41598-017-10406-x.
24. Mir M, Kim T, Majumder A, Xiang M, Wang R, Liu SC, et al. Labelfree characterization of emerging human neuronal networks. Sci Rep. 2014;4:4434. doi: 10.1038/srep04434.
25. Fisher M; Stroke Therapy Academic Industry Roundtable. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3. Stroke. 2003;34:1539-1546. doi: 10.1161/01.STR.0000072983.64326.53.
26. Albers GW, Goldstein LB, Hess DC, Wechsler LR, Furie KL, Gorelick PB, et al; STAIR VII Consortium. Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intraarterial and neuroprotective therapies. Stroke. 2011;42:2645-2650. doi: 10.1161/STROKEAHA.111.618850.
27. Otero-Ortega L, Laso-García F, Gómez-de Frutos MD, Rodríguez- Frutos B, Pascual-Guerra J, Fuentes B, et al. White matter repair after extracellular vesicles administration in an experimental animal model of subcortical stroke. Sci Rep. 2017;7:44433. doi: 10.1038/srep44433.
28. Zhang Y, Chopp M, Meng Y, Katakowski M, Xin H, Mahmood A, et al. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg. 2015;122:856-867. doi: 10.3171/2014.11.JNS14770.
29. Lövblad KO, Baird AE, Schlaug G, Benfield A, Siewert B, Voetsch B, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol. 1997;42:164-170. doi: 10.1002/ana.410420206.
30. Schellinger PD, Jansen O, Fiebach JB, Hacke W, Sartor K. A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke. 1999;30:765-768.
31. Ahmad AS, Satriotomo I, Fazal J, Nadeau SE, Doré S. Considerations for the optimization of induced white matter injury preclinical models. Front Neurol. 2015;6:172. doi: 10.3389/fneur.2015.00172.
32. Jokinen H, Gouw AA, Madureira S, Ylikoski R, van Straaten EC, van der Flier WM, et al; LADIS Study Group. Incident lacunes influence cognitive decline: the LADIS study. Neurology. 2011;76:1872-1878. doi: 10.1212/WNL.0b013e31821d752f.
33. Srikanth V, Beare R, Blizzard L, Phan T, Stapleton J, Chen J, et al. Cerebral white matter lesions, gait, and the risk of incident falls: a prospective population-based study. Stroke. 2009;40:175-180. doi: 10.1161/STROKEAHA.108.524355.
34. Li J, Ballif BA, Powelka AM, Dai J, Gygi SP, Hsu VW. Phosphorylation of ACAP1 by Akt regulates the stimulation-dependent recycling of integrin beta1 to control cell migration. Dev Cell. 2005;9:663-673. doi: 10.1016/j.devcel.2005.09.012.
35. Bax DV, Bernard SE, Lomas A, Morgan A, Humphries J, Shuttleworth CA, et al. Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by alpha 5 beta 1 and alpha v beta 3 integrins. J Biol Chem. 2003;278:34605-34616. doi: 10.1074/jbc.M303159200.
36. Ma YQ, Qin J, Plow EF. Platelet integrin alpha(IIb)beta(3): activation mechanisms. J Thromb Haemost. 2007;5:1345-1352. doi: 10.1111/j.1538-7836.2007.02537.x.
37. Webb DJ, Parsons JT, Horwitz AF. Adhesion assembly, disassembly and turnover in migrating cells - over and over and over again. Nat Cell Biol. 2002;4:E97-E100. doi: 10.1038/ncb0402-e97.
38. Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation. 2007;115:2323-2330. doi: 10.1161/CIRCULATIONAHA.107.691279.
39. Borsody M, Warner Gargano J, Reeves M, Jacobs B; MASCOTS Insula-Stroke Substudy Group. Infarction involving the insula and risk of mortality after stroke. Cerebrovasc Dis. 2009;27:564-571. doi: 10.1159/000214220.
40. Huisa BN, Neil WP, Schrader R, Maya M, Pereira B, Bruce NT, et al. Clinical use of computed tomographic perfusion for the diagnosis and prediction of lesion growth in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23:114-122. doi: 10.1016/j.jstrokecerebrovasdis.2012.10.020.
41. Schiemanck SK, Kwakkel G, Post MW, Prevo AJ. Predictive value of ischemic lesion volume assessed with magnetic resonance imaging for neurological deficits and functional outcome poststroke: a critical review of the literature. Neurorehabil Neural Repair. 2006;20:492-502. doi: 10.1177/1545968306289298.
42. Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology. 1998;50:864-870.
43. Nascimento LR, de Oliveira CQ, Ada L, Michaelsen SM, Teixeira- Salmela LF. Walking training with cueing of cadence improves walking speed and stride length after stroke more than walking training alone: a systematic review. J Physiother. 2015;61:10-15. doi: 10.1016/j.jphys.2014.11.015.
44. Hak L, Houdijk H, van der Wurff P, Prins MR, Beek PJ, van Dieën JH. Stride frequency and length adjustment in post-stroke individuals: influence on the margins of stability. J Rehabil Med. 2015;47:126-132. doi: 10.2340/16501977-1903.
45. Peterson CL, Hall AL, Kautz SA, Neptune RR. Pre-swing deficits in forward propulsion, swing initiation and power generation by individual muscles during hemiparetic walking. J Biomech. 2010;43:2348-2355. doi: 10.1016/j.jbiomech.2010.04.027.
46. Nolan KJ, Yarossi M, Mclaughlin P. Changes in center of pressure displacement with the use of a foot drop stimulator in individuals with stroke. Clin Biomech (Bristol, Avon). 2015;30:755-761. doi: 10.1016/j.clinbiomech.2015.03.016.
47. De Nunzio A, Zucchella C, Spicciato F, Tortola P, Vecchione C, Pierelli F, et al. Biofeedback rehabilitation of posture and weightbearing distribution in stroke: a center of foot pressure analysis. Funct Neurol. 2014;29:127-134.
48. Ng YS, Stein J, Ning M, Black-Schaffer RM. Comparison of clinical characteristics and functional outcomes of ischemic stroke in different vascular territories. Stroke. 2007;38:2309-2314. doi: 10.1161/STROKEAHA.106.475483.
49. Patterson KK, Parafianowicz I, Danells CJ, Closson V, Verrier MC, Staines WR, et al. Gait asymmetry in community-ambulating stroke survivors. Arch Phys Med Rehabil. 2008;89:304-310. doi: 10.1016/j.apmr.2007.08.142.